← Portfolio Scout

Portfolio company

Dendreon

Country not known yet

Raised

Not known yet

Latest stage

Not known yet

Rounds recorded

Not known yet

Backed by

1 investor

Sectors

Digital Health

About

This biopharmaceutical company manufactures autologous cellular immunotherapy for prostate cancer patients and provides end-to-end manufacturing services for the cellular therapy market.

Source

Funding history · 0

No rounds recorded yet. The agent looks for them over time.

Similar companies